Latest Articles

  • Clinical utility of warfarin pharmacogenomics (August 2013)
    D. Max Smith, BSPS, Cari Cristiani, PharmD, BCPS, BCACP, Kathryn A. Teng, MD and J. Kevin Hicks, PharmD, PhD
    Cleveland Clinic Journal of Medicine May 2015, 82 (5) 268-269; DOI: https://doi.org/10.3949/ccjm.82c.05001

    Readers comment on warfarin pharmacogenomics (August 2013).

  • In Reply: Pheochromocytoma (November 2014)
    Ricardo J. Pagán, MD
    Cleveland Clinic Journal of Medicine April 2015, 82 (4) 203; DOI: https://doi.org/10.3949/ccjm.82c.04002

    Readers comment on pheochromocytoma (November 2014) and pulmonary tuberculosis (January 2015).

  • Can the test for human papillomavirus DNA be used as a stand-alone, first-line screening test for cervical cancer?
    Xian Wen Jin, MD, PhD, FACP, Margaret L. McKenzie, MD and Belinda Yen-Lieberman, PhD
    Cleveland Clinic Journal of Medicine April 2015, 82 (4) 213-215; DOI: https://doi.org/10.3949/ccjm.82a.14092

    Yes. The FDA has approved the test for this indication, and guideline committees are reviewing the data.

  • A nonhealing oral ulcer in a man with HIV
    Lucía Turrión Merino, MD, Guillermo García Serrano, MD, Andres González García, MD, Eva Hermosa Zarza, MD, Marta Urech García De La Vega, MD, Rosario Carrillo Gijón, PhD and Pedro Jaén Olasolo, PhD
    Cleveland Clinic Journal of Medicine April 2015, 82 (4) 211-212; DOI: https://doi.org/10.3949/ccjm.82a.14059

    The workup eventually led to a diagnosis of oral tuberculosis secondary to active pulmonary tuberculosis.

  • A 57-year-old woman with abdominal pain
    Ranjita Pallavi, MD and Beata Popis-Matejak, MD
    Cleveland Clinic Journal of Medicine April 2015, 82 (4) 217-225; DOI: https://doi.org/10.3949/ccjm.82a.13171

    She was admitted with a diagnosis of acute diverticulitis, but then one thing led to another.

  • In Reply: Pulmonary tuberculosis (January 2015)
    Catherine A. Curley, MD
    Cleveland Clinic Journal of Medicine April 2015, 82 (4) 204; DOI: https://doi.org/10.3949/ccjm.82c.04004

    Readers comment on pheochromocytoma (November 2014) and pulmonary tuberculosis (January 2015).

  • The Surviving Sepsis Campaign: Where have we been and where are we going?
    R. Phillip Dellinger, MD, MSc, MCCM
    Cleveland Clinic Journal of Medicine April 2015, 82 (4) 237-244; DOI: https://doi.org/10.3949/ccjm.82gr.15001

    Evidence-based guidelines and performance-improvement practices will, it is hoped, reduce mortality from sepsis worldwide.

  • The art and science of clinical medicine and editorial policy
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine April 2015, 82 (4) 201-202; DOI: https://doi.org/10.3949/ccjm.82b.04015

    Most clinical decisions are made without any applicable data from clinical studies. This is the “art” of medicine.

  • Heart on the right may sometimes be ‘right’
    Prashant Sharma, MD, Vijaiganesh Nagarajan, MD, MRCP and Donald A. Underwood, MD
    Cleveland Clinic Journal of Medicine April 2015, 82 (4) 206-208; DOI: https://doi.org/10.3949/ccjm.81a.13163

    When a 76-year-old man presented with right-sided chest pain, his ECG suggested dextrocardia.

  • Resuming anticoagulation after hemorrhage: A practical approach
    Alison Colantino, MD, Amir K. Jaffer, MD, MBA and Daniel J. Brotman, MD
    Cleveland Clinic Journal of Medicine April 2015, 82 (4) 245-256; DOI: https://doi.org/10.3949/ccjm.82a.14047

    Foremost on our minds is the risk of another hemorrhage. Less obvious is the ongoing risk of thrombosis.

Pages